Company Overview - Spineway designs, manufactures, and markets innovative implants and surgical instruments for treating severe disorders of the spinal column [8] - The company has an international network of over 50 independent distributors, with 70% of its revenue coming from exports [8] General Meeting Highlights - The Combined General Meeting of Spineway shareholders was held on June 4, 2025, with 34,383,058 shares represented, accounting for 100% of voting rights [4] - Resolutions 1, 2, 3, 4, 6, 7, 8, 14, 15, 20, and 21 were approved, while resolutions 5, 9, 10, 11, 12, 13, 16, 17, 18, and 19 were rejected [5] Upcoming Events - The next significant date for the company is July 30, 2025, when half-year sales for 2025 will be reported [6] Regulatory Information - Spineway is eligible for PEA-SME (Equity Savings Plans for SMEs), indicating its compliance with certain regulatory frameworks [7]
Spineway : Minutes of the General Meeting of June 4, 2025
Globenewswireยท2025-06-06 16:32